# The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians

Study · id `cardio:ct-nct03819790` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03819790](<https://clinicaltrials.gov/study/NCT03819790>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03819790

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

## Technical summary

Registry record NCT03819790. Randomized; no masking; primary purpose treatment. Start 2018-10-02 (actual); primary completion 2019-11-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT03819790, source copy `cardio:ctgov-nct03819790-2021-02-25`, retrieved 2026-10-26)
- Started: 2018-10-02 (actual) (ClinicalTrials.gov record NCT03819790, source copy `cardio:ctgov-nct03819790-2021-02-25`, retrieved 2026-10-26)
- Primary completion: 2019-11-19 (actual) (ClinicalTrials.gov record NCT03819790, source copy `cardio:ctgov-nct03819790-2021-02-25`, retrieved 2026-10-26)
- Completion: 2019-11-19 (actual) (ClinicalTrials.gov record NCT03819790, source copy `cardio:ctgov-nct03819790-2021-02-25`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT03819790, source copy `cardio:ctgov-nct03819790-2021-02-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03819790-2021-02-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
- Acronym: VARIATION 2 SA
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Basal insulin glargine and lixisenatide
- Intervention (Drug): Basal insulin Basaglar/Lantus + gliclazide MR
- Intervention (Drug): Metformin
- Lead sponsor: LMC Diabetes & Endocrinology Ltd.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: LMC Diabetes & Endocrinology Ltd. (`cardio:org-lmc-diabetes-endocrinology-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in Participants of South Asian Origin With Type 2 Diabetes: VARIATION 2 SA Trial (`cardio:pubmed-35752566`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ef7b348c39601729dc23ee1d79494c2cd92a863dd20ddd9460390cb3332dae3d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
